1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro-

Request For Quotation
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Suppliers list
Company Name: Changzhou Hopschain Chemical Co.,Ltd.  
Tel: 85528066 13775048983
Email: sales@hopschem.com
Company Name: Xi'an Confluore Biological Technology Co., Ltd.  
Tel: +86-156-80926068 +86-15680926068
Email: 1924344760@qq.com
Company Name: Nanchang Tianzhen Biotechnology Co., Ltd  
Tel: 13758194781 13173652190
Email: 522013271@qq.com
Company Name: Xi'an Kaixin Biotechnology Co., Ltd  
Tel: 029-68881181 13619217766
Email: 3495811982@qq.com
Company Name: Xi'an Qiyue Biotechnology Co., Ltd.  
Tel: 400-400-6966-012-012 17778955912
Email: 2957605606@qq.com

1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- manufacturers

  • NODA-GA-NHS ester
  • NODA-GA-NHS ester pictures
  • 2025-06-07
  • CAS:1407166-70-4
  • Min. Order: 1g
  • Purity: >95.00%
  • Supply Ability: 1g
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Basic information
Product Name:1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro-
Synonyms:1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro-;2,2'-(7-(1-Carboxy-4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid;NODA-GA-NHS ester;2,2'-(7-(1-Carboxy-4-((2,5-dioxopyrrolidin-1-yl)oxy)-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetic acid , NODAGA-NHS
CAS:1407166-70-4
MF:C19H28N4O10
MW:472.45
EINECS:
Product Categories:
Mol File:1407166-70-4.mol
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Structure
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Chemical Properties
Boiling point 741.3±70.0 °C(Predicted)
density 1.52±0.1 g/cm3(Predicted)
pka1.99±0.10(Predicted)
Safety Information
MSDS Information
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Usage And Synthesis
UsesNODAGA-NHS (NODA-GA-NHS ester) is a [64]Cu chelator and the dissociated form of DOTA-trastuzumab in vivo. NODAGA-NHS was added in 0.1 M borate buffer at a ratio of 5/20/100 and was able to effectively bind trastuzumab (10 mg/mL) (4°C, 20 h). The copper content of the [64]Cu-NODAGA-trastuzumab was up to 80%. After blood was drawn from the caudal vein of mice, [64]Cu-NODAGA-trastuzumab was injected and showed good tumor uptake in mice expressing HER2 tumors, showing good PET imaging tracking ability.
IC 50RDC Bifunctional Chelator
1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro- Preparation Products And Raw materials
Tag:1H-1,4,7-Triazonine-1,4,7-triacetic acid, α1-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropyl]hexahydro-(1407166-70-4) Related Product Information
Rituximab EGFR Protein, HUMAN (621A.A, HEK293, FC) EGFR protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI) HER2/CD340 protein, HUMAN (BIOTINYLATED, HEK293, HIS) HER3 Protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI) AZD-9291